March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Effect Of Anti-vegf Drugs And Steroids On The Inner Blood-retinal Barrier, After Experimental BRVO In Rats
Author Affiliations & Notes
  • Peggy Bouzika
    Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
  • Nicole Gilodi
    Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
  • Alain Conti
    Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
  • Miltiadis K. Tsilimbaris
    Ophthalmology-Research Acct, University of Crete, Heraklion, Greece
  • Constantin J. Pournaras
    Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
  • Footnotes
    Commercial Relationships  Peggy Bouzika, None; Nicole Gilodi, None; Alain Conti, None; Miltiadis K. Tsilimbaris, None; Constantin J. Pournaras, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2965. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peggy Bouzika, Nicole Gilodi, Alain Conti, Miltiadis K. Tsilimbaris, Constantin J. Pournaras; Effect Of Anti-vegf Drugs And Steroids On The Inner Blood-retinal Barrier, After Experimental BRVO In Rats. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2965.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effect of anti-VEGF drugs and steroids on the inner blood-retinal barrier (BRB) function after experimental branch retinal vein occlusion (BRVO) in rats. The integrity of the barrier is related to the expression of occludins by retinal endothelial cells.

Methods: : Laser photocoagulation was applied to retinal veins of 12 Long-Evans rats, in order to induce BRVO. The occlusion was performed on the right eye of each animal, while the left eye was used as control. One day after the occlusion, the right eye of each animal was injected intravitreally with either artificial aqueous humor (n=4), bevacizumab (n=4) or triamcinolone (n=4). The animals were sacrificed 24 hours later; all retinas were harvested and prepared for indirect immunohistochemistry, using an anti-occluding primary antibody. The specimens were examined using a confocal microscope and images were acquired.

Results: : In normal retinas, occludins appeared as a dense, well-organised, fluorescent reticulum along the vascular wall. In eyes with BRVO, the structure of occludins was disrupted; irregular linear fluorescence appeared along occluded veins, while absence of fluorescence suggested down-regulation of occludin expression. Occludin distribution was much improved in animals having received treatment post BRVO.

Conclusions: : The administration of bevacizumab and triamcinolone post BRVO seems to improve the function of the inner BRB. This could explain macular edema reduction after the use of these drugs. These results are part of an ongoing experiment, which will include the use of combination therapy in the management of BRVO.

Keywords: retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×